Gabapentin Tablet, Coated
Product Images NDC 50268-325

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50268-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

50 (325 15)

50 (325 15)
Gabapentin tablets, USP at 600 mg strength are available in a bottle of 50 tablets (5 X 10) under prescription only. The product code is 5026852515. The rest of the text contains some errors and cannot be read.*
FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical Structure (Gabapenin 01)
FDA Label Image

Figure 1 (Gabapenin 02)

Figure 1 (Gabapenin 02)
This is a chart showing Mean Pain Score over a period of eight weeks, indicating a 4-week dose titration period followed by a 4-week fixed dose period. There are two treatment options shown: Placebo and Gabapentin at a dose of 3,600 mg/day. The Mean Pain Score is not explicitly written, but it can be inferred that it was measured on a numerical scale, with higher numbers indicating higher pain levels. No additional information is available.*
FDA Label Image

Figure 2 (Gabapenin 03)

Figure 2 (Gabapenin 03)
This appears to be a graph displaying the mean pain scores for a study that involved a three-week dose titration period followed by a four-week fixed dose period. The graph includes a placebo group and two groups receiving different doses of gabapentin (1,800mg/day and 2,400mg/day). Pain scores were recorded at baseline and at weeks 1-6. No further information is available from the given text.*
FDA Label Image

Figure 3 (Gabapenin 04)

Figure 3 (Gabapenin 04)
This appears to be a table or a chart representing percentages and possibly statistical significance levels denoted by asterisks next to p-values. However, without additional context or headings, it is difficult to determine what the chart is specifically displaying.*
FDA Label Image

Figure 4 (Gabapenin 05)

Figure 4 (Gabapenin 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.